Gilead Sciences Inc

Founded in 1987 Gilead Sciences is one of the leaders in the discovery and development of a new class of human therapeutics based on nucleotides the building blocks of DNA and RNA in the United States The company discovers develops and commercializes medications to advance the care of patients suffering from lifethreatening diseases Headquartered in Foster City Calif it serves North America Europe and Australia and employs a staff of more than 3400 individuals Gilead Sciences areas of focus include antivirals such as HIVAIDS and chronic hepatitis as well as cardiovascular conditions including pulmonary arterial hypertension and resistant hypertension The company also conducts studies on various respiratory diseases such as influenza and cystic fibrosis

Gilead Sciences Inc is a professional life sciences organization founded in 1987, recognized as a leader in the discovery and development of human therapeutics based on nucleotides—the building blocks of DNA and RNA. Focused on advancing care for patients with life-threatening diseases, Gilead discovers, develops, and commercializes medications that support treatment across multiple therapeutic areas. Based in Foster City, California, the company serves North America, Europe, and Australia and employs a staff of more than 3,400. Gilead’s expertise includes antivirals for conditions such as HIV/AIDS and chronic hepatitis, along with cardiovascular focus areas including pulmonary arterial hypertension and resistant hypertension. The company also conducts studies related to respiratory diseases such as influenza and cystic fibrosis. For directory users in Tampa, Florida, Gilead Sciences Inc represents a major, research-driven presence in therapeutics innovation with a clear commitment to addressing serious diseases through medication development.